<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2026 (7) TMI 1842 - MADRAS HIGH COURT</title>
    <link>https://www.taxtmi.com/caselaws?id=795956</link>
    <description>Food supplements purchased and sold unchanged could not be reclassified as proprietary Ayurvedic medicines for concessional taxation without proof of therapeutic character and compliance with drug-sale regulatory requirements. Applying the common parlance and authoritative tests, the notes state that a manufacturer&#039;s drug licence does not establish that the goods are medicines in the seller&#039;s hands, particularly where the seller lacks authority to deal in drugs and the products are not shown to diagnose, treat, mitigate or prevent disease. The statutory exclusion concerning Ayurvedic, Siddha and Unani drugs does not remove applicable licensing requirements. The products therefore remain residuary goods taxable at the higher rate; costs may also be awarded where no appellate provision prohibits them.</description>
    <language>en-us</language>
    <pubDate>Fri, 24 Jul 2026 00:00:00 +0530</pubDate>
    <lastBuildDate>Thu, 30 Jul 2026 08:52:46 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=914358" rel="self" type="application/rss+xml"/>
    <item>
      <title>2026 (7) TMI 1842 - MADRAS HIGH COURT</title>
      <link>https://www.taxtmi.com/caselaws?id=795956</link>
      <description>Food supplements purchased and sold unchanged could not be reclassified as proprietary Ayurvedic medicines for concessional taxation without proof of therapeutic character and compliance with drug-sale regulatory requirements. Applying the common parlance and authoritative tests, the notes state that a manufacturer&#039;s drug licence does not establish that the goods are medicines in the seller&#039;s hands, particularly where the seller lacks authority to deal in drugs and the products are not shown to diagnose, treat, mitigate or prevent disease. The statutory exclusion concerning Ayurvedic, Siddha and Unani drugs does not remove applicable licensing requirements. The products therefore remain residuary goods taxable at the higher rate; costs may also be awarded where no appellate provision prohibits them.</description>
      <category>Case-Laws</category>
      <law>VAT / Sales Tax</law>
      <pubDate>Fri, 24 Jul 2026 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=795956</guid>
    </item>
  </channel>
</rss>